ArticleJournal of cancer research and clinical oncology2019

Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?

Vérane Achard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.